Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Solid Sales Growth Makes These 5 Stocks Worth Betting On Now

Published 06/04/2018, 07:33 AM
Updated 07/09/2023, 06:31 AM
FITB
-
XEL
-
SYK
-
SSNC
-
AME
-

Investors often fail to consider sales growth as a dependable metric when it comes to selecting stocks. This might be because of their preconceived notion that a company’s price performance is typically sensitive to its earnings momentum. But betting on stocks depending totally on such a perception may not prove worthwhile.

It’s worth keeping in mind that in cases when companies incur a loss, albeit transitorily, they are valued on revenues and not earnings, as top-line growth (or decline) usually reflects a company’s future earnings performance. Notably, in contrast with price to earnings and price to book value ratios, which can turn negative and cease to be relevant, the price-to-sales (P/S) ratio is available even for firms that have hit choppy waters.

Also, a company can improve earnings by resorting to expense saving measures while maintaining stable revenues. However, superior profits could be achieved through continued revenue growth.

Further, earnings and book value are largely influenced by several factors including accounting decisions tied with depreciation, significant charges and inventory. But there are limited opportunities to manipulate sales, which further underscores the importance of P/S ratio.

A huge sales figure does not necessarily convert to profits. Hence, considering a company’s cash position along with its sales number can prove to be more prudent. Substantial cash in hand and a steady cash flow lend a company more flexibility with respect to business decisions and investments.

Selecting the Winning Stocks

In order to shortlist stocks that have witnessed impressive sales growth along with a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow more than $500 million as our main screening parameters.

But sales growth and cash strength are not the absolute criteria for selecting stocks. So, we added certain other factors to arrive at a winning strategy.

Price-to-Sales (P/S) Ratio less than X-Industry: This metric determines the value placed on each dollar of a company’s revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales.

% Change F1 Sales Estimate Revisions (four weeks) greater than X-Industry: Better-than-industry estimate revision has often been seen to trigger an increase in stock price.

Operating Margin (average last five years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs, an optimal situation for the company.

Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is translated into profits and the company is not hoarding cash. A high ROE means the company is spending wisely and is in all likelihood profitable.

Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment. You can see the complete list of today’s Zacks #1 Rank stocks here.

Here are five of the 13 stocks that qualified the screening:

Based in Kalamazoo, MI, Stryker Corporation (NYSE:SYK) is a medical technology company. Expected sales growth rate for the current year is 9.3% and the stock carries a Zacks Rank #2.

SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) offers software products and software-enabled services to financial services providers. This Windsor, CT-based company’s expected sales growth rate for 2018 is 100.8% and it carries a Zacks Rank #2.

Fifth Third Bancorp (NASDAQ:FITB) , headquartered in Cincinnati, OH, is a diversified financial services company. Its current-year expected sales growth rate is 9% and the stock sports a Zacks Rank #1.

Headquartered in Berwyn, PA, AMETEK, Inc. (NYSE:AME) manufactures and sells electronic instruments and electromechanical devices. The company’s expected sales growth rate for 2018 is 10.3% and it carries a Zacks Rank #2.

Xcel Energy Inc. (NASDAQ:XEL) is engaged mainly in the generation, purchase, transmission, distribution and sale of electricity. This Minneapolis, MN-based company’s sales are expected to grow at the rate of 3.4% for 2018 and the stock carries a Zacks Rank #2.

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance

Zacks Restaurant Recommendations: In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »



Xcel Energy Inc. (XEL): Free Stock Analysis Report

Fifth Third Bancorp (FITB): Free Stock Analysis Report

SS&C Technologies Holdings, Inc. (SSNC): Free Stock Analysis Report

Stryker Corporation (SYK): Free Stock Analysis Report

AMETEK, Inc. (AME): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.